BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21775172)

  • 1. Accuracy of high resolution (1.5 tesla) pelvic phased array magnetic resonance imaging (MRI) in staging prostate cancer in candidates for radical prostatectomy: results from a prospective study.
    Renard-Penna R; Rouprêt M; Comperat E; Ayed A; Coudert M; Mozer P; Xylinas E; Bitker MO; Grenier P
    Urol Oncol; 2013 May; 31(4):448-54. PubMed ID: 21775172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined endorectal and phased-array MRI in the prediction of pelvic lymph node metastasis in prostate cancer.
    Wang L; Hricak H; Kattan MW; Schwartz LH; Eberhardt SC; Chen HN; Scardino PT
    AJR Am J Roentgenol; 2006 Mar; 186(3):743-8. PubMed ID: 16498101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI of prostate cancer at 1.5 and 3.0 T: comparison of image quality in tumor detection and staging.
    Beyersdorff D; Taymoorian K; Knösel T; Schnorr D; Felix R; Hamm B; Bruhn H
    AJR Am J Roentgenol; 2005 Nov; 185(5):1214-20. PubMed ID: 16247137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of extraprostatic cancer by prostate specific antigen density, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer.
    Horiguchi A; Nakashima J; Horiguchi Y; Nakagawa K; Oya M; Ohigashi T; Marumo K; Murai M
    Prostate; 2003 Jun; 56(1):23-9. PubMed ID: 12746843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Staging of prostate cancer: value of the combined information of endorectal MRI, biopsy Gleason score, and preoperative PSA level].
    Wetter A; Ajdukovic AN; Fliessbach K; Lehnert T; Engl T; Jacobi V; Vogl TJ
    Rofo; 2006 Apr; 178(4):385-90. PubMed ID: 16607587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [MRI of prostate cancer using three different coil systems: image quality, tumor detection, and staging].
    Beyersdorff D; Darsow U; Stephan C; Schnorr D; Loening S; Taupitz M
    Rofo; 2003 Jun; 175(6):799-805. PubMed ID: 12811693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phased array magnetic resonance imaging for staging clinically localised prostrate cancer.
    Borre M; Lundorf E; Marcussen N; Langkilde NC; Wolf H
    Acta Oncol; 2005; 44(6):589-92. PubMed ID: 16294442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of phased-array 3.0-T and endorectal 1.5-T magnetic resonance imaging in the evaluation of local staging accuracy for prostate cancer.
    Park BK; Kim B; Kim CK; Lee HM; Kwon GY
    J Comput Assist Tomogr; 2007; 31(4):534-8. PubMed ID: 17882027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endorectal MR imaging before salvage prostatectomy: tumor localization and staging.
    Sala E; Eberhardt SC; Akin O; Moskowitz CS; Onyebuchi CN; Kuroiwa K; Ishill N; Zelefsky MJ; Eastham JA; Hricak H
    Radiology; 2006 Jan; 238(1):176-83. PubMed ID: 16373766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI of the prostate: interobserver agreement compared with histopathologic outcome after radical prostatectomy.
    Ruprecht O; Weisser P; Bodelle B; Ackermann H; Vogl TJ
    Eur J Radiol; 2012 Mar; 81(3):456-60. PubMed ID: 21354732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volume.
    Whitman EJ; Groskopf J; Ali A; Chen Y; Blase A; Furusato B; Petrovics G; Ibrahim M; Elsamanoudi S; Cullen J; Sesterhenn IA; Brassell S; Rittenhouse H; Srivastava S; McLeod DG
    J Urol; 2008 Nov; 180(5):1975-8; discussion 1978-9. PubMed ID: 18801539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer.
    D'Amico AV; Whittington R; Malkowicz SB; Schultz D; Schnall M; Tomaszewski JE; Wein A
    J Urol; 1995 Jul; 154(1):131-8. PubMed ID: 7539857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of pelvic phased array magnetic resonance imaging in staging of prostate cancer specifically in patients diagnosed with clinically locally advanced tumours by digital rectal examination.
    Xylinas E; Yates DR; Renard-Penna R; Seringe E; Bousquet JC; Comperat E; Bitker MO; Grenier P; Rouprêt M
    World J Urol; 2013 Aug; 31(4):881-6. PubMed ID: 22193518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the risk of positive surgical margins with pelvic phased-array magnetic resonance imaging in patients with clinically localized prostate cancer: a prospective study.
    Soulié M; Aziza R; Escourrou G; Seguin P; Tollon C; Molinier L; Bachaud J; Joffre F; Plante P
    Urology; 2001 Aug; 58(2):228-32. PubMed ID: 11489708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal--pelvic phased-array coils.
    Hricak H; White S; Vigneron D; Kurhanewicz J; Kosco A; Levin D; Weiss J; Narayan P; Carroll PR
    Radiology; 1994 Dec; 193(3):703-9. PubMed ID: 7972810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience improves staging accuracy of endorectal magnetic resonance imaging in prostate cancer: what is the learning curve?
    Latchamsetty KC; Borden LS; Porter CR; Lacrampe M; Vaughan M; Lin E; Conti N; Wright JL; Corman JM
    Can J Urol; 2007 Feb; 14(1):3429-34. PubMed ID: 17324322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer: local staging at 3-T endorectal MR imaging--early experience.
    Fütterer JJ; Heijmink SW; Scheenen TW; Jager GJ; Hulsbergen-Van de Kaa CA; Witjes JA; Barentsz JO
    Radiology; 2006 Jan; 238(1):184-91. PubMed ID: 16304091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Locoregional staging of prostatic carcinoma: accuracy of magnetic resonance with endorectal coil in 75 patients treated with radical prostatectomy].
    Gualdi GF; Casciani E; Ferriano MG; Polettini E
    Radiol Med; 1998 May; 95(5):498-505. PubMed ID: 9687928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of diffusional kurtosis imaging as a marker of adverse pathologic outcomes among prostate cancer active surveillance candidates undergoing radical prostatectomy.
    Rosenkrantz AB; Prabhu V; Sigmund EE; Babb JS; Deng FM; Taneja SS
    AJR Am J Roentgenol; 2013 Oct; 201(4):840-6. PubMed ID: 24059373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does body-coil magnetic-resonance imaging have a role in the preoperative staging of patients with clinically localized prostate cancer?
    Allen DJ; Hindley R; Clovis S; O'Donnell P; Cahill D; Rottenberg G; Popert R
    BJU Int; 2004 Sep; 94(4):534-8. PubMed ID: 15329107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.